
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded capsule containing lipoic acid, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing alpha lipoic acid is listed. Products containing it are filed in the directory as homeopathic products and unapproved drugs, in liquid, tablet, solution, spray and pellet forms. None of the listed products containing alpha lipoic acid is in capsule form.
This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Lipoic acid (alpha-lipoic acid) is a natural antioxidant sold as a dietary supplement, not an FDA-approved drug, that a pharmacy may compound when prescribed.
Alpha-lipoic acid, also called thioctic acid, is a sulfur-containing fatty acid that the body makes in mitochondria, where it serves as a cofactor for enzymes that turn nutrients into energy. It is also present in foods such as red meat, spinach, broccoli and potatoes. In its reduced form, dihydrolipoic acid, it neutralizes reactive oxygen species and helps regenerate other antioxidants such as vitamins C and E and glutathione, and it binds metals. It is not an FDA-approved drug: a search of FDA's Drugs@FDA database for lipoic acid returned no applications, and LiverTox states it has not been approved by FDA for any medical disease or condition. It is sold as a dietary supplement ingredient. A prescriber might order lipoic acid compounded in a particular form or combination. Compounded preparations are not FDA-approved and require a prescription.
Lipoic acid has no FDA drug label, so there are no labeled warnings, contraindications or interaction lists. LiverTox reports it is usually well tolerated; at higher amounts it can cause stomach discomfort, heartburn, nausea, constipation or diarrhea, dizziness and headache. It can lower blood sugar, so talk to your prescriber first if you have diabetes, and also if you have liver disease, a thyroid disorder, thiamine deficiency or drink large amounts of alcohol (StatPearls). A published analysis of 37 reported cases describes insulin autoimmune syndrome, a rare condition causing low blood sugar, linked to alpha-lipoic acid; get help for sweating, shakiness, confusion or other signs of low blood sugar. Large overdoses have caused seizures, severe acid buildup in the blood and organ failure; keep it away from children. StatPearls says more data are needed on use in pregnancy and that reliable breastfeeding data are lacking; talk to your prescriber before use if you are pregnant or nursing. Tell your prescriber or pharmacist about all medicines and supplements you take.
Alpha-lipoic acid is a dithiolane-containing, octanoic acid-derived fatty acid that is covalently bound as a cofactor of mitochondrial alpha-ketoacid dehydrogenase complexes. Both the oxidized form and dihydrolipoic acid scavenge reactive oxygen species; ALA regenerates vitamins C and E, increases glutathione synthesis, chelates metals, and inhibits I kappa B kinase, reducing NF-kB-driven cytokines (StatPearls). StatPearls states that absorption, distribution, metabolism and excretion are not well established; LiverTox notes it is absorbed from food to a variable extent and taken up by liver, kidney and brain. There is no FDA-approved indication; any use is not an FDA-approved indication. LiverTox reports that placebo-controlled trials in diabetic peripheral neuropathy showed mild improvements in surrogate markers without shown change in symptoms or progression, and rates it an unlikely cause of clinically apparent liver injury (likelihood score E). Insulin autoimmune syndrome attributed to ALA presents with fasting, nocturnal or late postprandial hypoglycemia, markedly raised insulin and positive insulin autoantibodies, and may begin during use or after stopping (Li 2021). Overdose features include lactic acidosis, rhabdomyolysis, seizures and multiorgan failure. Monitor glucose in patients with diabetes. No compounding-specific source was found. Dosing is per prescriber.
Swallow each capsule whole with a glass of water, unless your label says otherwise. Do not crush, chew or open the capsule unless your pharmacist tells you it is safe to do so. Take it at the times shown on your prescription label. If you miss a dose or are unsure how to take it, call the pharmacy.
Capsules are nonaqueous, so under USP <795> they usually carry a beyond-use date of up to 180 days when no other stability data apply. Keep the vial tightly closed at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard any capsules left after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth